NCT05531292 is a NA clinical trial of Model C0002 in Cataracts, sponsored by Johnson & Johnson Surgical Vision, Inc..

Who is sponsoring NCT05531292?

NCT05531292 is sponsored by Johnson & Johnson Surgical Vision, Inc..

What drugs are being tested in NCT05531292?

Interventions in NCT05531292: Model C0002, Model ZCB00/DCB00.

Is NCT05531292 still recruiting?

NCT05531292 is currently completed. Last updated 20 July 2025.

Last reviewed 2025-07-20 · How we verify

NCT05531292

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PROOF-OF-CONCEPT STUDY FOR NEW INTRAOCULAR LENS, MODEL C0002

Completed NA Last updated 20 July 2025

What this trial tests

NA trial testing Model C0002 in Cataracts in 106 participants. Completed in 20 May 2025.

Timeline

22 November 2022

Primary endpoint
20 May 2025

20 May 2025

Quick facts

Lead sponsor	Johnson & Johnson Surgical Vision, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	106
Start date	22 November 2022
Primary completion	20 May 2025
Estimated completion	20 May 2025
Sites	2 locations across France

Drugs / interventions tested

Model C0002
Model ZCB00/DCB00

Conditions studied

Cataracts — all drugs for Cataracts →

Sponsor

Johnson & Johnson Surgical Vision, Inc. — full company profile →

Who can join

Adults 60 to 75, any sex, with Cataracts. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, two-arm, randomized, bilateral, subject/evaluator-masked clinical study to evaluate the distance visual acuity, peripheral refractive error and functional vision of the EPV IOL compared to a standard monofocal control IOL.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Johnson & Johnson Surgical Vision, Inc. trials

Trials by the same sponsor.

NCT07324200 — Objective Assessment of Intraocular Lens Tilt and Decentration · recruiting
NCT07218419 — Comparison of Methods for Assessing Intraocular Lens Position · completed
NCT06797856 — Measurement of Refractive Error in Pseudophakic Eyes Using an Autorefractor and a Wavefront Aberrometer · completed
NCT05090787 — Clinical Investigation of the TECNIS 1-Piece Intraocular Lens · NA · withdrawn
NCT06767319 — Prospective, Multi-center, Non-interventional, Open Label, Randomized (Depth of Focus Testing Sequences), Clinical Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05531292 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Surgical Vision, Inc.
Last refreshed: 20 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05531292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing